|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/10 | |||
| A61K 47/16 | |||
| A61K 47/18 | |||
| A61K 9/14 | |||
| A61K 31/415 | |||
| A61K 31/4166 | |||
| A61P 39/00 |
| (11) | Number of the document | 1603513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04775816.4 |
| Date of filing the European patent application | 2004-03-01 | |
| (97) | Date of publication of the European application | 2005-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/006135 |
| Date | 2004-03-01 |
| (87) | Number | WO 2005/013919 |
| Date | 2005-02-17 |
| (30) | Number | Date | Country code |
| 451249 P | 2003-03-04 | US | |
| 539324 P | 2004-01-28 | US |
| (72) |
ANDERSON, David, US
CAMERANSI, Benjamin, G., US
CONKLIN, Vincent, M., US
|
| (73) |
Lyotropic Therapeutics, Inc.,
10487 Lakeridge Parkway 400, Ashland, VA 23005,
US
|
| (54) | DANTROLENE COMPOSITIONS |
| DANTROLENE COMPOSITIONS |